Overall market situation:
The mood on the European stock exchanges is mixed, but price movements remain within a fairly narrow range; the UK market is closed, the German DAX is gaining 0.76%, while the French CAC40 is losing 0.57%.
Start investing today or test a free demo
Create account Try a demo Download mobile app Download mobile appThe economic calendar for today's session focuses on the ISM PMI data for services from the US and quarterly reports from companies such as Palantir, Ford and Realty Income.
Distribution of today's returns for companies from Europe. Source: xStation
The German DE40 index is gaining 0.31% today on an intraday basis. The contract is holding above the 50-day EMA (blue line) and completely erasing the declines that started at the end of March. From a technical perspective (exponential EMA), the DE40 is resuming its upward trend and is already almost in the zone of historical highs. Source: xStation
News:
Novo Nordisk (NOVOB.DK) is up 0.7% after the FDA accepted the company’s application for oral Semaglutide 25 mg, which if approved would be the first oral GLP-1 treatment for obesity.
Volkswagen AG’s (VOW1.DE) Audi brand continues to struggle with low returns amid subdued demand in Europe and increasing competition in China. Despite this, the brand’s operating margin was 1.5% in the first quarter, a slight improvement from 1.1% in the same period last year. Furthermore, Audi’s revenue in Q1 was €15.43 billion, up 12.4% year-on-year. The brand delivered a total of 388,756 vehicles in Q1, down 3.3% year-on-year.
Shell (SHELL.NL) is working with advisers to evaluate a potential takeover of rival BP (BP.UK), but is waiting for further declines in stock and oil prices before deciding whether to make a bid, Bloomberg News reported Saturday, citing people familiar with the matter. The Dutch company’s shares are down nearly 2% today.
Other corporate news. Source: Bloomberg Financial LP
This content has been created by XTB S.A. This service is provided by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, entered in the register of entrepreneurs of the National Court Register (Krajowy Rejestr Sądowy) conducted by District Court for the Capital City of Warsaw, XII Commercial Division of the National Court Register under KRS number 0000217580, REGON number 015803782 and Tax Identification Number (NIP) 527-24-43-955, with the fully paid up share capital in the amount of PLN 5.869.181,75. XTB S.A. conducts brokerage activities on the basis of the license granted by Polish Securities and Exchange Commission on 8th November 2005 No. DDM-M-4021-57-1/2005 and is supervised by Polish Supervision Authority.
